HBW Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Herbalife's Frankos Sees GMP Challenges In New Light After Leaving FDA

This article was originally published in The Tan Sheet

Executive Summary

Vasilios "Bill" Frankos, former director of FDA's Division of Dietary Supplement Programs, left his mark on the industry after shepherding the supplement good manufacturing practices final rule from development to publication and through implementation
Advertisement

Related Content

Interview: CRN Vet Shao Brings Broad Industry Perspective To Herbalife
Fabricant Will Helm FDA Dietary Supplement Office
People In Brief
Herbalife Rides Daily Consumption To Q2 Earnings Jump, Revised Guidance
BI Nutraceuticals Extends Ingredient Sourcing Reach To Build Customer Base
Herbalife Touts Vertical Integration As Key To Traceability, Cost Control
FDA Will Enforce NDI Notification Requirement Without Warning
Herbalife Hires FDA's Frankos For Compliance/Safety Position
Herbalife Hires FDA's Frankos For Compliance/Safety Position
FDA Accomplishes A-List Goals, Will Publish NDI Guidance – CFSAN

Topics

Advertisement
UsernamePublicRestriction

Register

RS135056

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel